Markéta Límová

Summary

Country: USA

Publications

  1. ncbi New therapeutic options for chronic wounds
    Markéta Límová
    Wound and Ulcer Clinic, University of California San Francisco, San Francisco, CA, USA
    Dermatol Clin 20:357-63, ix. 2002
  2. ncbi Evaluation of two calcium alginate dressings in the management of venous ulcers
    Markéta Límová
    Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA
    Ostomy Wound Manage 49:26-33. 2003
  3. ncbi Controlled, randomized clinical trial of 2 hydrocolloid dressings in the management of venous insufficiency ulcers
    Markéta Límová
    Department of Dermatology, Medical Center, University of California San Francisco, 94115, USA
    J Vasc Nurs 20:22-32; quiz 33-4. 2002
  4. ncbi Active wound coverings: bioengineered skin and dermal substitutes
    Markéta Límová
    Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA
    Surg Clin North Am 90:1237-55. 2010

Detail Information

Publications4

  1. ncbi New therapeutic options for chronic wounds
    Markéta Límová
    Wound and Ulcer Clinic, University of California San Francisco, San Francisco, CA, USA
    Dermatol Clin 20:357-63, ix. 2002
    ..These include various growth factors, animal-derived wound coverings, and bioengineered human skin tissue...
  2. ncbi Evaluation of two calcium alginate dressings in the management of venous ulcers
    Markéta Límová
    Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA
    Ostomy Wound Manage 49:26-33. 2003
    ..As the different performance characteristics of various calcium alginate dressings become more obvious in clinical practice, further study is warranted to determine their optimal effectiveness...
  3. ncbi Controlled, randomized clinical trial of 2 hydrocolloid dressings in the management of venous insufficiency ulcers
    Markéta Límová
    Department of Dermatology, Medical Center, University of California San Francisco, 94115, USA
    J Vasc Nurs 20:22-32; quiz 33-4. 2002
    ..02). In this clinical study, hydrocolloid A demonstrated excellent performance characteristics and was highly effective in treating venous insufficiency ulcers...
  4. ncbi Active wound coverings: bioengineered skin and dermal substitutes
    Markéta Límová
    Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA
    Surg Clin North Am 90:1237-55. 2010
    ..These materials can protect the wound, increase healing, provide overall wound coverage, and improve patient care. The ideal skin substitute may soon become a reality...